Molecular and Cellular Biology · 2003 · 363 citations · 29 references
Life SciencesMolecular BiologyMolecular GeneticsTranscriptionTranscriptional RegulationVirologyTranscription ElongationTranscription FactorsTranscription InitiationViral TranscriptionBasal Transcription MachineryDominant Negative EffectsNegative Elongation FactorP-tefb RegulationRna-binding MotifViral Transcription ElongationViral Transcription FactorsViral Transcriptional Regulation
The elongation of transcription is a highly regulated process that requires negative and positive effectors. By binding the double-stranded stem in the transactivation response (TAR) element, RD protein from the negative transcription elongation factor (NELF) inhibits basal transcription from the long terminal repeat of the human immunodeficiency virus type 1 (HIVLTR). Tat and its cellular cofactor, the positive transcription elongation factor b (P-TEFb), overcome this negative effect. Cdk9 in P-TEFb also phosphorylates RD at sites next to its RNA recognition motif. A mutant RD protein that mimics its phosphorylated form no longer binds TAR nor represses HIV transcription. In sharp contrast, a mutant RD protein that cannot be phosphorylated by P-TEFb functions as a dominant-negative effector and inhibits Tat transactivation. These results better define the transition from abortive to productive transcription and thus replication of HIV.
29
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
Shaw-Yi Kao, Andrew F. Calman, Paul A. Luciw et al. · Nature · 1987 · 908 citations
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Yuerong Zhu, Tsafrira Peery, Junmin Peng et al. · Genes & Development · 1997 · 694 citations · Full text